Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 69.92B | 68.19B | 65.76B | 61.34B | 57.89B |
Gross Profit | 5.05B | 4.66B | 4.68B | 4.69B | 3.86B |
EBITDA | 4.77B | 4.83B | 3.23B | 4.40B | 3.10B |
Net Income | 1.63B | 1.19B | 737.00M | 1.48B | 690.00M |
Balance Sheet | |||||
Total Assets | 38.84B | 47.04B | 46.13B | 49.35B | 45.51B |
Cash, Cash Equivalents and Short-Term Investments | 4.48B | 4.67B | 4.45B | 4.65B | 3.70B |
Total Debt | 14.67B | 14.84B | 15.08B | 15.36B | 15.67B |
Total Liabilities | 27.23B | 35.37B | 33.90B | 33.71B | 33.45B |
Stockholders Equity | 11.67B | 11.67B | 12.24B | 15.66B | 12.08B |
Cash Flow | |||||
Free Cash Flow | 1.68B | 2.73B | 2.56B | 2.61B | -737.00M |
Operating Cash Flow | 2.92B | 3.84B | 3.81B | 3.79B | 640.00M |
Investing Cash Flow | -441.00M | -1.70B | -790.00M | -1.77B | 6.13B |
Financing Cash Flow | -2.94B | -1.86B | -3.19B | -2.23B | -7.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $35.34B | 17.88 | 15.35% | 4.47% | ― | ― | |
73 Outperform | $46.66B | 19.18 | 24.06% | 1.81% | -2.11% | 25.03% | |
72 Outperform | $15.63B | 35.95 | 35.74% | ― | 15.51% | 53.77% | |
71 Outperform | $12.49B | 13.49 | 31.26% | 2.71% | 1.46% | -26.54% | |
69 Neutral | $2.01B | 18.72 | 7.54% | 1.82% | 1.76% | 6.01% | |
65 Neutral | $26.92B | 15.40 | -4.18% | 3.18% | 1.01% | 1.53% | |
58 Neutral | $1.30B | 78.80 | 1.43% | ― | 10.37% | -73.84% |